277 related articles for article (PubMed ID: 18627333)
1. Argatroban use in heparin-induced thrombocytopenia.
Boggio LN; Oza VM
Expert Opin Pharmacother; 2008 Aug; 9(11):1963-7. PubMed ID: 18627333
[TBL] [Abstract][Full Text] [Related]
2. Argatroban for prevention and treatment of thromboembolism in heparin-induced thrombocytopenia.
Kondo LM; Wittkowsky AK; Wiggins BS
Ann Pharmacother; 2001 Apr; 35(4):440-51. PubMed ID: 11302409
[TBL] [Abstract][Full Text] [Related]
3. Argatroban anticoagulation for heparin induced thrombocytopenia in patients with ventricular assist devices.
Pappalardo F; Scandroglio AM; Potapov E; Stepanenko A; Maj G; Krabatsch T; Zangrillo A; Koster A; Hetzer R
Minerva Anestesiol; 2012 Mar; 78(3):330-5. PubMed ID: 22357371
[TBL] [Abstract][Full Text] [Related]
4. Argatroban anticoagulant therapy in patients with heparin-induced thrombocytopenia.
Lewis BE; Wallis DE; Berkowitz SD; Matthai WH; Fareed J; Walenga JM; Bartholomew J; Sham R; Lerner RG; Zeigler ZR; Rustagi PK; Jang IK; Rifkin SD; Moran J; Hursting MJ; Kelton JG;
Circulation; 2001 Apr; 103(14):1838-43. PubMed ID: 11294800
[TBL] [Abstract][Full Text] [Related]
5. Argatroban anticoagulation for heparin-induced thrombocytopenia in elderly patients.
Bartholomew JR; Pietrangeli CE; Hursting MJ
Drugs Aging; 2007; 24(6):489-99. PubMed ID: 17571914
[TBL] [Abstract][Full Text] [Related]
6. [Argatroban, a new antithrombotic treatment for heparin-induced thrombocytopenia application in cardiac surgery and in intensive care].
Rozec B; Boissier E; Godier A; Cinotti R; Stephan F; Blanloeil Y
Ann Fr Anesth Reanim; 2014; 33(9-10):514-23. PubMed ID: 25148720
[TBL] [Abstract][Full Text] [Related]
7. Argatroban therapy in heparin-induced thrombocytopenia.
Sparks ML
AACN Adv Crit Care; 2009; 20(1):37-43. PubMed ID: 19174636
[TBL] [Abstract][Full Text] [Related]
8. Treatment of heparin-induced thrombocytopenia: a practical argatroban dosing protocol for nurses.
Cypher S
J Infus Nurs; 2006; 29(6):318-25. PubMed ID: 17122687
[TBL] [Abstract][Full Text] [Related]
9. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia requiring renal replacement therapy.
Reddy BV; Grossman EJ; Trevino SA; Hursting MJ; Murray PT
Ann Pharmacother; 2005 Oct; 39(10):1601-5. PubMed ID: 16131539
[TBL] [Abstract][Full Text] [Related]
10. Argatroban for heparin-induced thrombocytopenia in hepato-renal failure and CVVHD.
Dager WE; White RH
Ann Pharmacother; 2003 Sep; 37(9):1232-6. PubMed ID: 12921505
[TBL] [Abstract][Full Text] [Related]
11. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia.
Lewis BE; Wallis DE; Leya F; Hursting MJ; Kelton JG;
Arch Intern Med; 2003 Aug 11-25; 163(15):1849-56. PubMed ID: 12912723
[TBL] [Abstract][Full Text] [Related]
12. Reducing harm associated with anticoagulation: practical considerations of argatroban therapy in heparin-induced thrombocytopenia.
Hursting MJ; Soffer J
Drug Saf; 2009; 32(3):203-18. PubMed ID: 19338378
[TBL] [Abstract][Full Text] [Related]
13. A randomized, open-label pilot study comparing desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis: PREVENT-HIT Study.
Boyce SW; Bandyk DF; Bartholomew JR; Frame JN; Rice L
Am J Ther; 2011 Jan; 18(1):14-22. PubMed ID: 21079512
[TBL] [Abstract][Full Text] [Related]
14. Effect of renal function on argatroban therapy in heparin-induced thrombocytopenia.
Guzzi LM; McCollum DA; Hursting MJ
J Thromb Thrombolysis; 2006 Dec; 22(3):169-76. PubMed ID: 17103051
[TBL] [Abstract][Full Text] [Related]
15. Argatroban dosing in patients with heparin-induced thrombocytopenia.
Verme-Gibboney CN; Hursting MJ
Ann Pharmacother; 2003; 37(7-8):970-5. PubMed ID: 12841802
[TBL] [Abstract][Full Text] [Related]
16. [Argatroban treatment of heparin-induced immune-mediated thrombocytopenia].
Nielsen JD; Heslet L
Ugeskr Laeger; 2009 Feb; 171(8):610-1. PubMed ID: 19284906
[TBL] [Abstract][Full Text] [Related]
17. Argatroban: a review of its use in the management of heparin-induced thrombocytopenia.
Dhillon S
Am J Cardiovasc Drugs; 2009; 9(4):261-82. PubMed ID: 19655821
[TBL] [Abstract][Full Text] [Related]
18. Argatroban: a direct thrombin inhibitor with reliable and predictable anticoagulant actions.
Escolar G; Bozzo J; Maragall S
Drugs Today (Barc); 2006 Apr; 42(4):223-36. PubMed ID: 16703119
[TBL] [Abstract][Full Text] [Related]
19. Rationale and design of the PREVENT-HIT study: a randomized, open-label pilot study to compare desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis.
Frame JN; Rice L; Bartholomew JR; Whelton A
Clin Ther; 2010 Apr; 32(4):626-36. PubMed ID: 20435232
[TBL] [Abstract][Full Text] [Related]
20. Safety and economic considerations of argatroban use in critically ill patients: a retrospective analysis.
Kim SC; Tran N; Schewe JC; Boehm O; Wittmann M; Graeff I; Hoeft A; Baumgarten G
J Cardiothorac Surg; 2015 Feb; 10():19. PubMed ID: 25879883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
